Soluble CD146, a biomarker and a target for preventing resistance to anti-angiogenic therapy in glioblastoma

被引：0
|
作者：
Ahmad Joshkon
Emeline Tabouret
Wael Traboulsi
Richard Bachelier
Stéphanie Simoncini
Sandrine Roffino
Carine Jiguet-Jiglaire
Bassam Badran
Benjamin Guillet
Alexandrine Foucault-Bertaud
Aurelie S. Leroyer
Françoise Dignat-George
Olivier Chinot
Hussein Fayyad-Kazan
Nathalie Bardin
Marcel Blot-Chabaud
机构：
[1] Aix-Marseille University,Department of Neuro
[2] INSERM1263,Oncology
[3] INRAE1260,Laboratory of Cancer Biology and Molecular Immunology, Faculty of Science
[4] C2VN,Department of Radiopharmacy
[5] Aix-Marseille University,undefined
[6] APHM,undefined
[7] CNRS,undefined
[8] INP,undefined
[9] Service de Neuro-Oncologie CHU Timone,undefined
[10] Hôpitaux de Marseille,undefined
[11] CNRS,undefined
[12] ISM UMR 7287,undefined
[13] Aix-Marseille University,undefined
[14] Lebanese University,undefined
[15] La Timone University Hospital,undefined
[16] CERIMED,undefined
[17] Aix-Marseille University,undefined
来源：
Acta Neuropathologica Communications | / 10卷
关键词：
Soluble CD146; Biomarker; Therapeutic antibody; Bevacizumab; Glioblastoma;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
相关论文
共 50 条
  • [1] Soluble CD146, a biomarker and a target for preventing resistance to anti-angiogenic therapy in glioblastoma
    Joshkon, Ahmad
    Tabouret, Emeline
    Traboulsi, Wael
    Bachelier, Richard
    Simoncini, Stephanie
    Roffino, Sandrine
    Jiguet-Jiglaire, Carine
    Badran, Bassam
    Guillet, Benjamin
    Foucault-Bertaud, Alexandrine
    Leroyer, Aurelie S.
    Dignat-George, Francoise
    Chinot, Olivier
    Fayyad-Kazan, Hussein
    Bardin, Nathalie
    Blot-Chabaud, Marcel
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2022, 10 (01)
  • [2] CD146/Soluble CD146 Pathway Is a Novel Biomarker of Angiogenesis and Inflammation in Proliferative Diabetic Retinopathy
    Abu El-Asrar, Ahmed M.
    Nawaz, Mohd Imtiaz
    Ahmad, Ajmal
    Siddiquei, Mohammad Mairaj
    Allegaert, Eef
    Gikandi, Priscilla W.
    De Hertogh, Gert
    Opdenakker, Ghislain
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2021, 62 (09)
  • [3] soluble CD146: A new angiogenic factor involved in physiopathology
    Harhouri, Karim
    Bardin, Nathalie
    Dignat-George, Francoise
    Blot-Chabaud, Marcel
    THROMBOSIS RESEARCH, 2012, 130 : S108 - S108
  • [4] VEGF ISOFORMS AS OUTCOME BIOMARKER FOR ANTI-ANGIOGENIC THERAPY IN RECURRENT GLIOBLASTOMA
    D'Alessandris, Quintino Giorgio
    Martini, Maurizio
    Cenci, Tonia
    Capo, Gabriele
    Ricci-Vitiani, Lucia
    Larocca, Luigi Maria
    Pallini, Roberto
    NEUROLOGY, 2015, 84 (18) : 1906 - 1908
  • [5] Evading anti-angiogenic therapy: resistance to anti-angiogenic therapy in solid tumors
    Dey, Nandini
    De, Pradip
    Brian, Leyland-Jones
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2015, 7 (10): : 1675 - 1698
  • [6] Soluble CD146 and APS: a potential biomarker of obstetrical complications?
    Kaspi, E.
    Chabaud, M. B.
    George, F. D.
    Bardin, N.
    LUPUS, 2012, 21 (07) : 779 - 780
  • [7] Gene expression changes underlying glioblastoma resistance to anti-angiogenic therapy
    Chen, William C.
    Jahangiri, Arman
    Yagnik, Garima
    Sidorov, Maxim
    Rick, Jonathan
    Kuang, Ruby
    DeLay, Michael
    Aghi, Manish K.
    CANCER RESEARCH, 2016, 76
  • [8] Revisiting anti-angiogenic therapy for recurrent glioblastoma
    Peters, Katherine B.
    TRANSLATIONAL CANCER RESEARCH, 2019, 8 : S569 - S572
  • [9] New Directions in Anti-Angiogenic Therapy for Glioblastoma
    Nancy Wang
    Rakesh K. Jain
    Tracy T. Batchelor
    Neurotherapeutics, 2017, 14 : 321 - 332
  • [10] New Directions in Anti-Angiogenic Therapy for Glioblastoma
    Wang, Nancy
    Jain, Rakesh K.
    Batchelor, Tracy T.
    NEUROTHERAPEUTICS, 2017, 14 (02) : 321 - 332
12345